Leak Proof PDBBind: A Reorganized Dataset of Protein-Ligand Complexes for More Generalizable Binding Affinity Prediction
暂无分享,去创建一个
[1] Michael R. Shirts,et al. Development and Benchmarking of Open Force Field 2.0.0: The Sage Small Molecule Force Field , 2023, Journal of chemical theory and computation.
[2] Guolin Ke,et al. Do Deep Learning Models Really Outperform Traditional Approaches in Molecular Docking? , 2023, ArXiv.
[3] Vineet D. Menachery,et al. Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro , 2023, ACS central science.
[4] Yingkai Zhang,et al. CovBinderInPDB: A Structure-Based Covalent Binder Database , 2022, J. Chem. Inf. Model..
[5] Chengtao Li,et al. TANKBind: Trigonometry-Aware Neural NetworKs for Drug-Protein Binding Structure Prediction , 2022, bioRxiv.
[6] Dongwei Kang,et al. Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity , 2022, Journal of medicinal chemistry.
[7] P. Pan,et al. Boosting Protein-Ligand Binding Pose Prediction and Virtual Screening Based on Residue-Atom Distance Likelihood Potential and Graph Transformer. , 2022, Journal of medicinal chemistry.
[8] Arnold N. Tharrington,et al. Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor , 2022, ACS pharmacology & translational science.
[9] Vignesh Ram Somnath,et al. Multi-Scale Representation Learning on Proteins , 2022, NeurIPS.
[10] Y. Orba,et al. Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19 , 2022, Journal of medicinal chemistry.
[11] T. Jaakkola,et al. EquiBind: Geometric Deep Learning for Drug Binding Structure Prediction , 2022, ICML.
[12] Jike Wang,et al. InteractionGraphNet: A Novel and Efficient Deep Graph Representation Learning Framework for Accurate Protein-Ligand Interaction Predictions. , 2021, Journal of medicinal chemistry.
[13] G. Wei,et al. Perspectives on SARS-CoV-2 Main Protease Inhibitors. , 2021, Journal of medicinal chemistry.
[14] J. Louis,et al. Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease , 2021, Journal of medicinal chemistry.
[15] Alice Hooper,et al. Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro) , 2021, Journal of medicinal chemistry.
[16] M. Vignuzzi,et al. Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 , 2021, Science.
[17] Scott J. Miller,et al. Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease , 2021, Structure.
[18] Diogo Santos-Martins,et al. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings , 2021, J. Chem. Inf. Model..
[19] S. Cherry,et al. Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors , 2021, Journal of medicinal chemistry.
[20] Diana C. F. Monteiro,et al. X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease , 2021, Science.
[21] Farren J. Isaacs,et al. Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations , 2021, ACS central science.
[22] C. Schiffer,et al. Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188 , 2021, Viruses.
[23] Dan Li,et al. Accuracy or novelty: what can we gain from target-specific machine-learning-based scoring functions in virtual screening? , 2021, Briefings Bioinform..
[24] Z. Xi,et al. New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders. , 2021, Annual review of pharmacology and toxicology.
[25] Michael R. Shirts,et al. Development and Benchmarking of Open Force Field v1.0.0-the Parsley Small-Molecule Force Field. , 2020, Journal of chemical theory and computation.
[26] Jaechang Lim,et al. PIGNet: a physics-informed deep learning model toward generalized drug–target interaction predictions , 2020, Chemical science.
[27] Kunqian Yu,et al. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients , 2020, Acta Pharmacologica Sinica.
[28] Farnaz Heidar-Zadeh,et al. Learning to Make Chemical Predictions: the Interplay of Feature Representation, Data, and Machine Learning Methods. , 2020, Chem.
[29] Holger Gohlke,et al. Converging a Knowledge-Based Scoring Function: DrugScore2018 , 2018, J. Chem. Inf. Model..
[30] Yan Li,et al. Comparative Assessment of Scoring Functions: The CASF-2016 Update , 2018, J. Chem. Inf. Model..
[31] P. Sanseau,et al. Drug repurposing: progress, challenges and recommendations , 2018, Nature Reviews Drug Discovery.
[32] Kwong-Sak Leung,et al. The Impact of Protein Structure and Sequence Similarity on the Accuracy of Machine-Learning Scoring Functions for Binding Affinity Prediction , 2018, Biomolecules.
[33] Arzucan Özgür,et al. DeepDTA: deep drug–target binding affinity prediction , 2018, Bioinform..
[34] Sheng-yong,et al. Structural insights into drug development strategy targeting EGFR T790M/C797S , 2018, Oncotarget.
[35] C. Yun,et al. Structural basis of mutant-selectivity and drug-resistance related to CO-1686. , 2017, Oncotarget.
[36] Yang Li,et al. Structural and Sequence Similarity Makes a Significant Impact on Machine-Learning-Based Scoring Functions for Protein-Ligand Interactions , 2017, J. Chem. Inf. Model..
[37] C. Eigenbrot,et al. 4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase. , 2016, Bioorganic & medicinal chemistry letters.
[38] C. Eigenbrot,et al. Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFR. , 2016, ACS medicinal chemistry letters.
[39] J. Smaill,et al. Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed. , 2015, Journal of structural biology.
[40] Michael K. Gilson,et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..
[41] Jie Li,et al. PDB-wide collection of binding data: current status of the PDBbind database , 2015, Bioinform..
[42] Vijay S Pande,et al. Building Force Fields: An Automatic, Systematic, and Reproducible Approach. , 2014, The journal of physical chemistry letters.
[43] P. Lyu,et al. Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors. , 2013, Journal of medicinal chemistry.
[44] Yoshikazu Ohta,et al. Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors. , 2013, ACS medicinal chemistry letters.
[45] C. Lindsley,et al. Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease. , 2013, Journal of medicinal chemistry.
[46] A. Luxen,et al. Development of New Drugs for an Old Target — The Penicillin Binding Proteins , 2012, Molecules.
[47] G. V. Paolini,et al. Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.
[48] Xiaoqin Zou,et al. Scoring functions and their evaluation methods for protein-ligand docking: recent advances and future directions. , 2010, Physical chemistry chemical physics : PCCP.
[49] John B. O. Mitchell,et al. A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking , 2010, Bioinform..
[50] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[51] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[52] Zhihai Liu,et al. Comparative Assessment of Scoring Functions on a Diverse Test Set , 2009, J. Chem. Inf. Model..
[53] Mary Adams,et al. Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases. , 2008, Bioorganic & medicinal chemistry letters.
[54] M. Meyerson,et al. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP , 2008, Proceedings of the National Academy of Sciences.
[55] Matthew Meyerson,et al. Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. , 2007, Cancer cell.
[56] Xin Wen,et al. BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..
[57] M. Jacobson,et al. Molecular mechanics methods for predicting protein-ligand binding. , 2006, Physical chemistry chemical physics : PCCP.
[58] I. Muegge. PMF scoring revisited. , 2006, Journal of medicinal chemistry.
[59] Matthew P. Repasky,et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.
[60] Marcel L Verdonk,et al. General and targeted statistical potentials for protein–ligand interactions , 2005, Proteins.
[61] Krystal J Alligood,et al. A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib) , 2004, Cancer Research.
[62] Roy S Herbst,et al. Review of epidermal growth factor receptor biology. , 2004, International journal of radiation oncology, biology, physics.
[63] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[64] M. Sliwkowski,et al. Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor* , 2002, The Journal of Biological Chemistry.
[65] G. Klebe,et al. Knowledge-based scoring function to predict protein-ligand interactions. , 2000, Journal of molecular biology.
[66] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[67] L. R. Dice. Measures of the Amount of Ecologic Association Between Species , 1945 .
[68] E. Maréchal. Measuring Bioactivity: KI, IC50 and EC50 , 2011 .
[69] William L. Jorgensen,et al. Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..
[70] Luhua Lai,et al. Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..
[71] John A. Nelder,et al. A Simplex Method for Function Minimization , 1965, Comput. J..
[72] Christus,et al. A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins , 2022 .